GBP1 antibody | knockout validation | Abcam ab131255

This is a knockout-validated antibody summary, based on the publication "Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

GBP1 antibody | knockout validation | Abcam ab131255 figure 1
Figure 1. Western blotting results of GBP1 protein expression in the control and GBP1 KO cells. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: GBP1

Catalog number: ab131255

Summary: Rabbit monoclonal IgG against a synthetic peptide within human GBP1 (aa 550-650). Suitable for western blot, immunohistochemistry (paraffin), and immunocytochemistry/immunofluorescence. Unsuitable for flow cytometry or immunoprecipitation.

Validation Method

Western blot

Sample

Control and GBP1-KO human prostate cancer cell lines DU145 and PC3.

Blocking agent

5% non-fat dry milk in Tris-buffered saline with Tween-20 (TBST) for 2 h at room temperature.

Primary incubation

1:500 dilution.

Detection

ECL Plus kit (Thermo Scientific, USA).

References
  1. Zhao J, Li X, Liu L, Cao J, Goscinski M, Fan H, et al. Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer. Front Oncol. 2019;9:1494 pubmed publisher